Crucell Receives US Patent Covering its STAR(TM) Technology
06-Apr-2005
The newly issued patent is the first and basic patent in a portfolio pertaining to the STAR(TM) technology developed by professor Arie Otte of Chromagenics B.V., a company acquired by Crucell in March 2004. The patent generally covers the identification and selection of so-called STAR(TM) sequences that find use in boosting the production of therapeutic proteins in cell-culture systems.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.